{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T22:48:46Z","timestamp":1790808526764,"version":"4.1.0"},"reference-count":54,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2021,10,23]],"date-time":"2021-10-23T00:00:00Z","timestamp":1634947200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCDD"],"abstract":"<jats:p>Turner syndrome is a rare disorder resulting from complete or partial loss of the second sex chromosome. Common manifestations include delayed growth, premature ovarian failure, congenital heart defects, endocrine disorders, lymphedema, and webbed neck. People with Turner syndrome have significantly increased mortality risk primarily due to cardiovascular abnormalities. The mechanisms that lead to these defects are not completely understood and are obscured by the significant variability of both karyotype and phenotype without consistent correlation between the two. This paper presents a review of the recent literature surrounding the symptoms, mechanisms, diagnosis, and treatment of Turner syndrome with a focus on cardiovascular manifestations. With technological advancements in genetics, the molecular processes of Turner syndrome have begun to be dissected. Certain genes on the X chromosome that typically escape inactivation have been implicated in both specific manifestations and broader risk categories. Recently identified genome-wide epigenetic changes may help explain the variability in presentation. It remains unclear as to how the combination of these factors results in the overall clinical picture, but advances in genomic, genetic, epigenetic, and -omics technology hold promise for providing insights that will improve the medical management of individuals with Turner syndrome.<\/jats:p>","DOI":"10.3390\/jcdd8110138","type":"journal-article","created":{"date-parts":[[2021,10,24]],"date-time":"2021-10-24T22:06:16Z","timestamp":1635113176000},"page":"138","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["A Review of Recent Developments in Turner Syndrome Research"],"prefix":"10.3390","volume":"8","author":[{"given":"Allen C.","family":"Huang","sequence":"first","affiliation":[{"name":"Medical School, Oregon Health & Science University, Portland, OR 97239, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan B.","family":"Olson","sequence":"additional","affiliation":[{"name":"Department of Molecular and Medical Genetics, Oregon Health & Science University, Portland, OR 97239, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3976-6284","authenticated-orcid":false,"given":"Cheryl L.","family":"Maslen","sequence":"additional","affiliation":[{"name":"Knight Cardiovascular Institute, Oregon Health & Science University, Portland, OR 97239, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,10,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1210\/jc.2006-0558","article-title":"Prevalence, Incidence, Diagnostic Delay, and Mortality in Turner Syndrome","volume":"91","author":"Stochholm","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/s41574-019-0224-4","article-title":"Turner syndrome: Mechanisms and management","volume":"15","author":"Gravholt","year":"2019","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1210\/er.2011-1059","article-title":"Cardiovascular phenotype in Turner syndrome--integrating cardiol-ogy, genetics, and endocrinology","volume":"33","author":"Mortensen","year":"2012","journal-title":"Endocr. Rev."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"e000048","DOI":"10.1161\/HCG.0000000000000048","article-title":"Cardiovascular Health in Turner Syndrome: A Scientific Statement From the American Heart Association","volume":"11","author":"Silberbach","year":"2018","journal-title":"Circ. Genom. Precis. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1002\/ajmg.a.61310","article-title":"Recognition and management of adults with Turner syndrome: From the transition of adolescence through the senior years","volume":"179","author":"Lin","year":"2019","journal-title":"Am. J. Med. Genet. Part A."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/ajmg.c.31675","article-title":"Turner syndrome: New insights from prenatal genomics and transcriptomics","volume":"181","author":"Bianchi","year":"2019","journal-title":"Am. J. Med. Genet. Part C Semin. Med. Genet."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/gim.2013.77","article-title":"Single-nucleotide polymorphism array genotyping is equivalent to metaphase cytogenetics for diagnosis of Turner syndrome","volume":"16","author":"Prakash","year":"2014","journal-title":"Genet. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e1021","DOI":"10.5435\/JAAOS-D-17-00796","article-title":"Orthopaedic Manifestations in Turner Syndrome","volume":"27","author":"Acosta","year":"2019","journal-title":"J. Am. Acad. Orthop. Surg."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1210\/jc.2006-1374","article-title":"Care of Girls and Women with Turner Syndrome: A Guideline of the Turner Syndrome Study Group","volume":"92","author":"Bondy","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1136\/heartjnl-2017-312658","article-title":"Cardiovascular imaging in Turner syndrome: State-of-the-art practice across the lifespan","volume":"104","author":"Mortensen","year":"2018","journal-title":"Heart"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1080\/13697137.2018.1501674","article-title":"Endocrinopathies and cardiopathies in patients with Turner syndrome","volume":"21","author":"Allybocus","year":"2018","journal-title":"Climacteric"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3949\/ccjm.85a.17069","article-title":"Bicuspid aortic valve: Basics and beyond","volume":"85","author":"Shah","year":"2018","journal-title":"Clevel. Clin. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e1220","DOI":"10.1542\/peds.2006-0776","article-title":"Prolonged Rate-Corrected QT Interval and Other Electrocardiogram Abnormalities in Girls with Turner Syndrome","volume":"118","author":"Bondy","year":"2006","journal-title":"Pediatrics"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/HCO.0b013e3283129b89","article-title":"Aortic dissection in Turner syndrome","volume":"23","year":"2008","journal-title":"Curr. Opin. Cardiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1161\/CIRCULATIONAHA.111.088633","article-title":"Moderate aortic enlargement and bicuspid aortic valve are associated with aortic dissection in Turner syndrome: Report of the international turner syndrome aortic dissection registry","volume":"126","author":"Carlson","year":"2012","journal-title":"Circulation"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1002\/ajmg.a.37208","article-title":"Aortic dimensions in Turner syndrome","volume":"167","author":"Quezada","year":"2015","journal-title":"Am. J. Med. Genet. Part A"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1161\/HYPERTENSIONAHA.115.07065","article-title":"Pilot Study of Blood Pressure in Girls With Turner Syndrome: An Awareness Gap, Clinical Associations, and New Hypotheses","volume":"68","author":"Los","year":"2016","journal-title":"Hypertension"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1210\/jc.2009-0384","article-title":"X-Chromosome Gene Dosage and the Risk of Diabetes in Turner Syndrome","volume":"94","author":"Bakalov","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/ajmg.c.31678","article-title":"Cardiometabolic health in Turner syndrome","volume":"181","author":"Davis","year":"2019","journal-title":"Am. J. Med. Genet. Part C Semin. Med. Genet."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0022-3476(95)70551-1","article-title":"Lipid abnormalities in Turner syndrome","volume":"126","author":"Ross","year":"1995","journal-title":"J. Pediatr."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.repc.2017.08.008","article-title":"Cardiovascular risk in Turner syndrome","volume":"37","author":"Donato","year":"2018","journal-title":"Rev. Port. Cardiol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1210\/er.2006-0005","article-title":"Germ Cell Tumors in the Intersex Gonad: Old Paths, New Directions, Moving Frontiers","volume":"27","author":"Cools","year":"2006","journal-title":"Endocr. Rev."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/ajmg.c.31683","article-title":"Epigenetics and genomics in Turner syndrome","volume":"181","author":"Viuff","year":"2019","journal-title":"Am. J. Med. Genet. Part C Semin. Med. Genet."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1530\/EJE-18-0878","article-title":"X chromosome gene dosage as a determinant of congenital malformations and of age-related comorbidity risk in patients with Turner syndrome, from childhood to early adulthood","volume":"180","author":"Fiot","year":"2019","journal-title":"Eur. J. Endocrinol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/ajmg.c.31691","article-title":"The impact of somatic mosaicism on bicuspid aortic valve and aortic dissection in Turner Syndrome","volume":"181","author":"Prakash","year":"2019","journal-title":"Am. J. Med. Genet. Part C Semin. Med. Genet."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/cen.12481","article-title":"X chromosome parental origin and aortic stiffness in turner syndrome","volume":"81","author":"Bakalov","year":"2014","journal-title":"Clin. Endocrinol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/ajmg.c.31669","article-title":"Conference summary: What we have learned and where we are headed","volume":"181","author":"Maslen","year":"2019","journal-title":"Am. J. Med. Genet. Part C Semin. Med. Genet."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/ajmg.c.31688","article-title":"The state of Turner syndrome science: Are we on the threshold of discovery?","volume":"181","author":"Kruszka","year":"2019","journal-title":"Am. J. Med. Genet. Part C Semin. Med. Genet."},{"key":"ref_29","first-page":"28","article-title":"How do genes that escape from X-chromosome inactivation contribute to Turner syndrome?","volume":"181","author":"Peeters","year":"2019","journal-title":"Am. J. Med. Genet. Part C Semin. Med. Genet."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1093\/hmg\/9.5.695","article-title":"The short stature homeobox gene SHOX is involved in skeletal abnormalities in Turner syn-drome","volume":"9","author":"Schiller","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1159\/000488347","article-title":"Congenital Hyperinsulinism in Infants with Turner Syndrome: Possible Association with Monosomy X and KDM6A Haploinsufficiency","volume":"89","author":"Gibson","year":"2018","journal-title":"Horm. Res. Paediatr."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/ajmg.c.31673","article-title":"Clinical update on sensorineural hearing loss in Turner syndrome and the X-chromosome","volume":"181","author":"Bonnard","year":"2019","journal-title":"Am. J. Med. Genet. Part C Semin. Med. Genet."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.devcel.2011.11.009","article-title":"UTX, a histone H3-lysine 27 demethylase, acts as a critical switch to activate the cardiac de-velopmental program","volume":"22","author":"Lee","year":"2012","journal-title":"Dev. Cell"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/ajmg.c.31686","article-title":"The genetic basis of Turner syndrome aortopathy","volume":"181","author":"Corbitt","year":"2019","journal-title":"Am. J. Med. Genet. Part C Semin. Med. Genet."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1158\/1535-7163.MCT-17-0646","article-title":"Matrix Metalloproteinase Inhibitors in Cancer Therapy: Turning Past Failures Into Future Successes","volume":"17","author":"Winer","year":"2018","journal-title":"Mol. Cancer Ther."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Corbitt, H., Morris, S.A., Gravholt, C.H., Mortensen, K.H., Tippner-Hedges, R., Silberbach, M., and Maslen, C.L. (2018). GenTAC Registry Investigators TIMP3 and TIMP1 are risk genes for bicuspid aortic valve and aortopathy in Turner syndrome. PLoS Genet., 14.","DOI":"10.1371\/journal.pgen.1007692"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1002\/ajmg.a.37953","article-title":"Autosomal and X chromosome structural variants are associated with congenital heart defects in Turner syndrome: The NHLBI GenTAC registry","volume":"170","author":"Prakash","year":"2016","journal-title":"Am. J. Med. Genet. Part A"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"34220","DOI":"10.1038\/srep34220","article-title":"Widespread DNA hypomethylation and differential gene expression in Turner syndrome","volume":"6","author":"Trolle","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s11882-016-0612-y","article-title":"Epigenetic Dysfunction in Turner Syndrome Immune Cells","volume":"16","author":"Thrasher","year":"2016","journal-title":"Curr. Allergy Asthma Rep."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13148-018-0477-0","article-title":"Epigenetics in Turner syndrome","volume":"10","author":"Lanes","year":"2018","journal-title":"Clin. Epigenetics"},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Manotas, M.C., Calder\u00f3n, J.C., L\u00f3pez-Kleine, L., Su\u00e1rez-Obando, F., Moreno, O.M., and Rojas, A. (2020). Identification of common differentially expressed genes in Turner (45,X) and Klinefelter (47,XXY) syndromes using bioinformatics analysis. Mol. Genet. Genom. Med., 8.","DOI":"10.1002\/mgg3.1503"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/ng1663","article-title":"Global hypomethylation of the genome in XX embryonic stem cells","volume":"37","author":"Zvetkova","year":"2005","journal-title":"Nat. Genet."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2174\/138920208783884883","article-title":"The Epigenetic Origin of Aneuploidy","volume":"9","author":"Prada","year":"2008","journal-title":"Curr. Genom."},{"key":"ref_44","first-page":"108","article-title":"A hypothesis: Could telomere length and\/or epigenetic alterations contribute to infertility in females with Turner syndrome?","volume":"181","year":"2019","journal-title":"Am. J. Med. Genet. C. Semin. Med. Genet."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"E1241","DOI":"10.1210\/jc.2011-3488","article-title":"Parental Origin of the X-Chromosome Does Not Influence Growth Hormone Treatment Effect in Turner Syndrome","volume":"97","author":"Devernay","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1002\/ajmg.10506","article-title":"Parental origin of normal X chromosomes in Turner syndrome patients with various karyotypes: Impli-cations for the mechanism leading to generation of a 45,X karyotype","volume":"111","author":"Uematsu","year":"2002","journal-title":"Am. J. Med. Genet."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000480499","article-title":"Parental Origin of the Retained X Chromosome in Monosomy X Miscarriages and Ongoing Pregnancies","volume":"45","author":"Grande","year":"2017","journal-title":"Fetal Diagn. Ther."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ics.2006.06.008","article-title":"Genomic imprinting in Turner syndrome","volume":"1298","author":"Bondy","year":"2006","journal-title":"Int. Congr. Ser."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1136\/jmg.28.3.151","article-title":"A cytogenetic and molecular study of a series of 45,X fetuses and their parents","volume":"28","author":"Cockwell","year":"1991","journal-title":"J. Med. Genet."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1093\/jhered\/esn027","article-title":"Genotype, phenotype, and karyotype correlation in the X0 mouse model of Turner Syndrome","volume":"99","author":"Probst","year":"2008","journal-title":"J. Hered."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/ajmg.c.31681","article-title":"The mouse as a model of fundamental concepts related to Turner syndrome","volume":"181","author":"Arnold","year":"2019","journal-title":"Am. J. Med. Genet. Part C Semin. Med. Genet."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Lopes, A.M., Burgoyne, P.S., Ojarikre, A., Bauer, J., Sargent, C.A., Amorim, A., and Affara, N.A. (2010). Transcriptional changes in response to X chromosome dosage in the mouse: Implications for X inactiva-tion and the molecular basis of Turner Syndrome. BMC Genom., 11.","DOI":"10.1186\/1471-2164-11-82"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1161\/ATVBAHA.120.314407","article-title":"Monosomy X in Female Mice Influences the Regional Formation and Augments the Severity of Angioten-sin II-Induced Aortopathies","volume":"41","author":"AlSiraj","year":"2021","journal-title":"Arter. Thromb. Vasc. Biol."},{"key":"ref_54","first-page":"190","article-title":"Preliminary Evidence for Aortopathy and an X-Linked Parent-of-Origin Effect on Aortic Valve Malfor-mation in a Mouse Model of Turner Syndrome","volume":"2","author":"Hinton","year":"2015","journal-title":"J. Cardiovasc. Dev. Dis."}],"container-title":["Journal of Cardiovascular Development and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2308-3425\/8\/11\/138\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:21:48Z","timestamp":1760167308000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2308-3425\/8\/11\/138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,23]]},"references-count":54,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,11]]}},"alternative-id":["jcdd8110138"],"URL":"https:\/\/doi.org\/10.3390\/jcdd8110138","relation":{},"ISSN":["2308-3425"],"issn-type":[{"value":"2308-3425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,23]]}}}